Back to search

Article

Binding of Specific S100 Proteins Inhibits Activity of Tumor Necrosis Factor

2022-11-16

Abstract excerpt

Tumor necrosis factor (TNF) inhibitors (anti-TNFs) represent a cornerstone of the treatment of various immune-mediated inflammatory diseases and are among the most commercially successful therapeutic agents. Knowledge of TNF binding partners is critical for identification of the factors able to affect clinical efficacy of the anti-TNFs. Here we report that among eighteen representatives of the multifunctional S100...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0caeb235-7999-501c-a0a9-446ca4c9106c
DOI
10.20944/preprints202211.0313.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Binding of Specific S100 Proteins Inhibits Activity of Tumor Necrosis FactorDOI 10.20944/preprints202211.0313.v1
Select a neighboring publication to make it the new centre.